Anzeige
Mehr »
Donnerstag, 30.10.2025 - Börsentäglich über 12.000 News
Weltweiter Kaliboom treibt Nachfrage - ACM positioniert sich im 93,5 Mrd. USD-Markt bis 2032!!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A0B7QK | ISIN: GB0034330679 | Ticker-Symbol: DWV
Frankfurt
30.10.25 | 08:01
0,001 Euro
+100,00 % +0,001
Branche
Dienstleistungen
Aktienmarkt
Sonstige
1-Jahres-Chart
CELLBXHEALTH PLC Chart 1 Jahr
5-Tage-Chart
CELLBXHEALTH PLC 5-Tage-Chart
RealtimeGeldBriefZeit
0,0270,02916:14

Aktuelle News zur CELLBXHEALTH Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MiANGLE plc changes name to CelLBxHealth, updates stock ticker2
MiAngle PLC - Change of Name-
MoAIM Market Roundup: Angle, Coyngar, Light Science Technologies1
16.10.IN BRIEF: Angle names Peter Collins as interim CEO1
16.10.Angle Appoints Peter Collins As Interim CEO1
CELLBXHEALTH Aktie jetzt für 0€ handeln
16.10.ANGLE plc Announces Appointments: Interim CEO and Senior Board Advisor179GUILFORD, SURREY / ACCESS Newswire / October 16, 2025 / ANGLE plc (to be renamed CelLBxHealth plc) (AIM:AGL)(OTCQX:ANPCY), a world-leading circulating tumour cell (CTC) intelligence company with tests...
► Artikel lesen
08.10.Angle touts planned name and strategy change, Groen turns executive11
08.10.Angle PLC Announces Strategy Update156Appointment of Executive Chairman, proposed change of name and strategy updateCompany to pursue revised strategy and name change to CelLBxHealth plcDr. Jan Groen, the current Non-Executive Chairman...
► Artikel lesen
29.09.Angle PLC Announces Presentation of Data on Glioblastoma175CLINICAL study SHOWS DETECTION OF CTCs in glioblastoma PatientsGBM CTC isolation only possible with Parsortix label-free methodologyData presented at the 7th ACTC meeting GUILDFORD, SURREY / ACCESS...
► Artikel lesen
29.09.Angle: Presentation of Data on Glioblastoma-
12.09.IN BRIEF: Angle CEO and finance lead step down after shareholder talks1
12.09.Angle founder and CEO steps down after shareholder backlash1
12.09.Angle CEO and finance director resign2
12.09.Angle PLC Announces Board Changes307GUILDFORD, SURREY / ACCESS Newswire / September 12, 2025 / ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a world-leading liquid biopsy company with innovative circulating tumour cell (CTC) solutions for use in...
► Artikel lesen
09.09.Shares in Angle tumble on gloomy outlook2
09.09.Angle H1 Pre-tax Loss Widens, Lowers FY25 Guidance; Stock Down5
09.09.Angle shares suffer as interim loss widens amid weaker revenue3
09.09.Angle PLC Announces Change of Adviser150APPOINTMENT OF NOMINATED ADVISER AND SOLE BROKER GUILDFORD, SURREY / ACCESS Newswire / September 9, 2025 / ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a world-leading liquid biopsy company with innovative circulating...
► Artikel lesen
09.09.Angle PLC Announces Interim Results208ANGLE plc("ANGLE" or "the Company")Interim Results for the six months ended 30 June 2025COMMERCIALISATION PROGRESSED ACROSS MULTIPLE FRONTS DESPITE REVENUE PRESSURE FROM ADVERSE MARKET CONDITIONSLarge...
► Artikel lesen
05.09.Angle PLC Announces Notice of Results245ANGLE plc ("the Company") Notice of Interim Results and Webcast GUILDFORD, SURREY / ACCESS Newswire / September 5, 2025 / ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a world-leading liquid biopsy company with...
► Artikel lesen
Weiter >>
60 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1